Delivery Order SPE2DB22D1041-SPE2DB25FUCL6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $10,879.54. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a delivery order valued at $4,967.18 to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count supply) on May 8, 2025, with an ultimate completion date of May 9, 2025. This is a firm fixed-price, non-set-aside contract with performance at the vendor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the Defense Logistics Agency....
- The Defense Logistics Agency awarded a delivery order valued at $2,224.30 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 8 mg tablets (90-count) on September 19, 2025, with an ultimate completion date of September 22, 2025. The contract represents a firm fixed price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 vehicle designed to support global...
- The Defense Logistics Agency awarded a $60,591.71 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90, with completion expected by September 5, 2025. This is a firm fixed price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count) with a ceiling value of $1,171.70. This competitive, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of July 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.86 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $5,286.57 to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units. This is a firm fixed-price delivery order with an ultimate completion date of June 2, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The pharmaceut ical product—an antihypertensive medication—will be delivered to the company's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units. This competitively awarded, non-set-aside contract carries a ceiling value of $11,345.80 under a firm fixed-price arrangement, with performance to be completed by August 15, 2025, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Candesartan Cilexetil is an angiotensin II...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles) with a ceiling value of $1,175.41. This firm fixed-price delivery order, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24,...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUCL6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Candesartan Cilexetil 16 mg tablets (90-count) with a ceiling value of $5,419.60. This competitively awarded, firm fixed-price contract, which carries no set-aside designation, is performance-based through September 26, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The delivery order represents a child action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $1 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive range of pharmaceutical products including brand-name and generic medications across multiple therapeutic domains. This particular delivery order for Candesartan Cilexetil—an antihypertensive medication—exemplifies the contractor's role in fulfilling routine pharmaceutical supply needs for the Defense Health Agency and other federal healthcare systems through established contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/25/25 |